Drug Profile
PS 724
Latest Information Update: 23 Aug 2002
Price :
$50
*
At a glance
- Originator Millennium Pharmaceuticals
- Class Antineoplastics
- Mechanism of Action Ras protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 09 Sep 1998 Preclinical development for Cancer in USA (Unknown route)